Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients

An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment

NCT00737009 ·Status: COMPLETED

Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy

NCT00542594 ·Status: TERMINATED

Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients

NCT02132000 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer

NCT00002581 ·Status: COMPLETED ·Phase: PHASE3

Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer

NCT00003016 ·Status: UNKNOWN ·Phase: PHASE3

Therapeutic Dose Monitoring (TDM) of Tamoxifen

NCT05133674 ·Status: UNKNOWN ·Phase: PHASE2

Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer

NCT00078832 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment

NCT01596530 ·Status: TERMINATED ·Phase: PHASE1

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

NCT00530868 ·Status: COMPLETED ·Phase: PHASE2

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

NCT00638391 ·Status: COMPLETED

3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer

NCT00300508 ·Status: COMPLETED ·Phase: PHASE3

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

NCT00291759 ·Status: COMPLETED ·Phase: PHASE3

Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density

NCT00238316 ·Status: COMPLETED ·Phase: PHASE2

Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer

NCT00096369 ·Status: TERMINATED ·Phase: PHASE2

Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer

NCT00357110 ·Status: COMPLETED ·Phase: PHASE2

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

NCT01151215 ·Status: TERMINATED ·Phase: PHASE2

Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer

NCT00301457 ·Status: COMPLETED ·Phase: PHASE3

Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting

NCT00322647 ·Status: COMPLETED

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer

NCT00248170 ·Status: COMPLETED ·Phase: PHASE3

Patient's Anastrozole Compliance to Therapy Programme

NCT00555867 ·Status: TERMINATED

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer

NCT00003418 ·Status: UNKNOWN ·Phase: PHASE3

Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer

NCT00002579 ·Status: COMPLETED ·Phase: PHASE3

Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

NCT00332852 ·Status: COMPLETED ·Phase: PHASE3

Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up

NCT01357772 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Liver Safety Under Upfront Arimidex vs Tamoxifen

NCT00537771 ·Status: COMPLETED ·Phase: PHASE4